Skip to content
10-Q

Quarterly Report

KRAIG BIOCRAFT LABORATORIES, INC. KBLB

0001493152-23-040575

← back to feed
Filed
Nov 13, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents Q3 2023 · Sep 30, 2023 $2.89M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $3.86M
Current Liabilities Q3 2023 · Sep 30, 2023 $8.57M
Current Liabilities Q3 2023 · Dec 31, 2022 $8.07M
Total Liabilities Q3 2023 · Sep 30, 2023 $8.63M
Total Liabilities Q3 2023 · Dec 31, 2022 $8.09M
Current Assets Q3 2023 · Sep 30, 2023 $3M
Current Assets Q3 2023 · Dec 31, 2022 $3.98M
Total Assets Q3 2023 · Sep 30, 2023 $3.63M
Total Assets Q3 2023 · Dec 31, 2022 $4.57M
Stock Issued Q3 2023 · Feb 16, 2023 2.43M sh
Stock Issued Q3 2023 · Feb 15, 2022 7.4M sh
Shares Diluted Q3 2023 · Sep 30, 2022 976.59M sh
Shares Diluted Q3 2023 · Sep 30, 2022 960.03M sh
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$1.45M
Stockholders Equity Q3 2023 · Sep 30, 2022 −$3.79M
Stockholders Equity Q3 2023 · Jun 30, 2022 −$3.77M
Stockholders Equity Q3 2023 · Dec 31, 2021 −$5.3M
Eps Diluted Q3 2023 · Sep 30, 2022 $0.00
Eps Diluted Q3 2023 · Sep 30, 2022 $0.00
Eps Basic Q3 2023 · Sep 30, 2022 $0.00
Eps Basic Q3 2023 · Sep 30, 2022 $0.00
Sga Expense Q3 2023 · Sep 30, 2022 $207.17K
Sga Expense Q3 2023 · Sep 30, 2022 $632.61K
Rd Expense Q3 2023 · Sep 30, 2022 $62.12K
Rd Expense Q3 2023 · Sep 30, 2022 $139.49K
Net Income Q3 2023 · Sep 30, 2022 −$810.36K
Net Income Q3 2023 · Sep 30, 2022 −$2.9M
Operating Income Q3 2023 · Sep 30, 2022 −$525.28K
Operating Income Q3 2023 · Sep 30, 2022 −$1.61M